What Is Nayzilam and What Does It Treat?
Nayzilam (midazolam nasal spray) is an FDA-approved benzodiazepine for treating seizure clusters in people with epilepsy aged 12 and older. It stops or reduces prolonged or repeated seizures that don't respond to standard rescue meds. Administered nasally, it works fast—peak blood levels in 10-20 minutes—to calm overactive brain activity.[1][2]
Does Nayzilam Help Stop Seizure Clusters?
Yes, clinical trials show it helps in most cases. In a key study of 143 patients, 53.7% achieved seizure freedom for 60 minutes after one dose, rising to 63.2% with a second dose if needed. Another trial reported 73.3% seizure cessation within an hour. It's more effective than placebo and matches or exceeds rectal diazepam, with easier home use.[2][3]
How Quickly Does Nayzilam Work?
It acts within minutes via nasal absorption, with effects starting in 5-10 minutes for many users. Full seizure control often occurs by 30 minutes. Patients or caregivers can give it outside medical settings, unlike IV options.[1][4]
Common Side Effects and Risks
Sedation (up to 68%), sleepiness (31%), headache (15%), and nasal discomfort (9%) are frequent. Serious risks include respiratory depression, especially if combined with opioids or alcohol—can lead to coma or death. Not for daily use; limit to 1-2 doses per cluster, max 5 episodes monthly. Overuse risks dependence.[2][5]
How Does Nayzilam Compare to Other Rescue Meds?
| Treatment | Form | Onset | Efficacy (Seizure Stop in 30-60 min) | Ease of Use |
|-----------|------|--------|-------------------------------------|-------------|
| Nayzilam | Nasal spray | 5-10 min | 50-70% | High (self/no caregiver training) |
| Diastat (diazepam) | Rectal gel | 5-15 min | 45-55% | Low (invasive, embarrassing) |
| Valtoco (diazepam) | Nasal spray | 10-20 min | 50-60% | High |
| Intranasal midazolam (off-label) | Generic spray | Similar | Comparable | Varies |
Nayzilam edges out rectal options for convenience, with similar efficacy to other nasals.[3][6]
Who Should Avoid Nayzilam?
Not for those with glaucoma, severe lung issues, or allergies to benzodiazepines. Use caution in elderly, pregnant people (Category D risk), or with CNS depressants. Requires prescription; train on proper technique to avoid dosing errors.[1][5]
Cost, Access, and Patent Status
A single-dose kit costs $600-800 without insurance; copays vary. UCB manufactures it. No generic yet—key patents expire around 2032, per DrugPatentWatch.[7][8]
Sources:
[1] FDA Label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209050s000lbl.pdf
[2] Nayzilam.com (PI): https://nayzilam.com/
[3] Lancet Neurology (RYE study): https://pubmed.ncbi.nlm.nih.gov/31474530/
[4] Epilpesy.com: https://www.epilepsy.com/treatment/devices/nayzilam
[5] Drugs.com: https://www.drugs.com/nayzilam.html
[6] Valtoco comparison (Epilepsia): https://pubmed.ncbi.nlm.nih.gov/34407288/
[7] GoodRx pricing: https://www.goodrx.com/nayzilam
[8] DrugPatentWatch: https://www.drugpatentwatch.com/p/tradename/NAYZILAM